JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 100 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $102,000 | -19.7% | 15,009 | +21.7% | 0.01% | -22.2% |
| Q1 2021 | $127,000 | -56.8% | 12,335 | -80.1% | 0.01% | -60.9% |
| Q1 2020 | $294,000 | +153.4% | 61,968 | +367.0% | 0.02% | +228.6% |
| Q4 2019 | $116,000 | +28.9% | 13,268 | -50.7% | 0.01% | +40.0% |
| Q3 2019 | $90,000 | -40.8% | 26,900 | -12.4% | 0.01% | -44.4% |
| Q2 2019 | $152,000 | -43.1% | 30,700 | -28.8% | 0.01% | -40.0% |
| Q1 2019 | $267,000 | – | 43,112 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |